CN1733101A - 治疗子宫内膜异位的中药 - Google Patents
治疗子宫内膜异位的中药 Download PDFInfo
- Publication number
- CN1733101A CN1733101A CN 200410024553 CN200410024553A CN1733101A CN 1733101 A CN1733101 A CN 1733101A CN 200410024553 CN200410024553 CN 200410024553 CN 200410024553 A CN200410024553 A CN 200410024553A CN 1733101 A CN1733101 A CN 1733101A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- treatment
- lodd
- radix
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 201000009273 Endometriosis Diseases 0.000 title abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 10
- 241001489978 Eupolyphaga Species 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 9
- 240000000920 Typhonium flagelliforme Species 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 241000180649 Panax notoginseng Species 0.000 abstract description 2
- 235000003143 Panax notoginseng Nutrition 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 235000008671 Calycanthus floridus Nutrition 0.000 abstract 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000759833 Cornus officinalis Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 240000006927 Foeniculum vulgare Species 0.000 abstract 1
- 235000002176 Foeniculum vulgare var vulgare Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 244000148992 Lindera benzoin Species 0.000 abstract 1
- 235000004520 Lindera benzoin Nutrition 0.000 abstract 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 16
- 230000000694 effects Effects 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- ZFMSMUAANRJZFM-UHFFFAOYSA-N Estragole Chemical compound COC1=CC=C(CC=C)C=C1 ZFMSMUAANRJZFM-UHFFFAOYSA-N 0.000 description 2
- LHXDLQBQYFFVNW-UHFFFAOYSA-N Fenchone Chemical compound C1CC2(C)C(=O)C(C)(C)C1C2 LHXDLQBQYFFVNW-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- YTZSBJLNMIQROD-SFBCHFHNSA-N Morroniside Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)O[C@@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YTZSBJLNMIQROD-SFBCHFHNSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 2
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- -1 flavone compound Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- DTGKSKDOIYIVQL-QXFUBDJGSA-N (-)-borneol Chemical compound C1C[C@]2(C)[C@H](O)C[C@H]1C2(C)C DTGKSKDOIYIVQL-QXFUBDJGSA-N 0.000 description 1
- 229930006703 (-)-borneol Natural products 0.000 description 1
- KZNQSIGXNNTADH-UZMCECQYSA-N (1S,9S,10R,12S)-4-(methoxymethyl)-9-methyl-13-methylidene-6-oxatetracyclo[7.4.0.03,7.010,12]trideca-3(7),4-diene Chemical compound O(Cc1c2c(oc1)C[C@]1(C)[C@H](C(=C)[C@@H]3[C@H]1C3)C2)C KZNQSIGXNNTADH-UZMCECQYSA-N 0.000 description 1
- YTZSBJLNMIQROD-UHFFFAOYSA-N (4aS)-1c-beta-D-glucopyranosyloxy-6xi-hydroxy-8t-methyl-(4ar,8ac)-5,6,8,8a-tetrahydro-1H,4aH-pyrano[3,4-c]pyran-4-carboxylic acid methyl ester Natural products C12C(C)OC(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O YTZSBJLNMIQROD-UHFFFAOYSA-N 0.000 description 1
- BZQURGSQMBBPRU-DZGCQCFKSA-N (4as,8as)-3,8a-dimethyl-5-methylidene-4,4a,6,9-tetrahydrobenzo[f][1]benzofuran Chemical compound C([C@]1(C)C2)=CCC(=C)[C@@H]1CC1=C2OC=C1C BZQURGSQMBBPRU-DZGCQCFKSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000007415 Anhedonia Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- CSDLSTWDMOAXRY-PJODQICGSA-N Isolinderoxide Natural products O(Cc1c2c(oc1)C[C@]1(C)[C@@H]3[C@H](C(C)=C1C2)C3)C CSDLSTWDMOAXRY-PJODQICGSA-N 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- KZNQSIGXNNTADH-UHFFFAOYSA-N Linderoxide Natural products COCc1coc2CC3(C)C4CC4C(=C)C3Cc12 KZNQSIGXNNTADH-UHFFFAOYSA-N 0.000 description 1
- BZQURGSQMBBPRU-ZFWWWQNUSA-N Lindestrene Natural products C=C1[C@H]2[C@@](C)(C=CC1)Cc1occ(C)c1C2 BZQURGSQMBBPRU-ZFWWWQNUSA-N 0.000 description 1
- JQICWKRTHOPTEO-YDHLFZDLSA-N Lindestrenolide Natural products O=C1C(C)=C2[C@@H](O1)C[C@@]1(C)[C@H](C(=C)CC=C1)C2 JQICWKRTHOPTEO-YDHLFZDLSA-N 0.000 description 1
- JQICWKRTHOPTEO-UHFFFAOYSA-N Lindoestrenolid Natural products C1C2C(=C)CC=CC2(C)CC2C1=C(C)C(=O)O2 JQICWKRTHOPTEO-UHFFFAOYSA-N 0.000 description 1
- AMBQHHVBBHTQBF-UHFFFAOYSA-N Loganin Natural products C12C(C)C(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O AMBQHHVBBHTQBF-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 208000000450 Pelvic Pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 1
- PLSSBWGEYMENGJ-UHFFFAOYSA-N Villoside Natural products CC1CCC2C1C(=O)OCC2COC1OC(CO)C(O)C(O)C1O PLSSBWGEYMENGJ-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- VMGUBSLDEXOUMH-CQDKDKBSSA-N hydroxylindestrenolide Natural products O=C1C(C)=C2[C@@](O)(O1)C[C@@]1(C)[C@H](C(=C)CC=C1)C2 VMGUBSLDEXOUMH-CQDKDKBSSA-N 0.000 description 1
- CSHHAYKTXXQCBB-UHFFFAOYSA-N icosanoic acid;octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCCCC(O)=O CSHHAYKTXXQCBB-UHFFFAOYSA-N 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000000854 inhibitional effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- AMBQHHVBBHTQBF-UOUCRYGSSA-N loganin Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AMBQHHVBBHTQBF-UOUCRYGSSA-N 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 230000008557 oxygen metabolism Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了治疗子宫内膜异位的中药，所述中药的组份按重量比为杜仲10～15g、山茱萸10～15g、桃仁10～15g、益母草10～15g、红花10～15g、乌药3～5g、小茴香3～5g、败酱草15～20g、桂枝9～12g、鳖甲10～15g、田三七粉9～12g、土鳖虫9～12g、甘草3～6g，上述诸药配伍使用对有效治疗子宫内膜异位有独特功效，治疗时间短，效果显著，而且无任何副作用。
Description
技术领域
本发明涉及中药药物领域，更具体的说，涉及一种治疗子宫内膜异位的中药配方。
背景技术
子宫内膜异位症发病率占生育年龄妇女的5％-20％。其主要表现为继发性病经、性交瘤、盆腔痛、月经异常、不孕等。目前对子宫内膜异位症的治疗主要有：口服西药，手术治疗和中医治疗。口服西药西医一般采用激素疗法，但是，激素疗法副作用太大，治疗有其局限性，而手术治疗对生育年龄的妇女来说，很难接受。一般手术的复发率在80％以上，而且手术本身的创伤，就容易使子宫内膜产生异位。中药治疗，中药治疗历史已经很久，由于中药独有的用药安全性、无创伤和治疗效果好而受到患者的欢迎。
发明内容
本发明的目的是提供一种疗效显著，无副作用的治疗子宫内膜异位的中药。
为实现上述目的，本实用新型的技术方案是：治疗子宫内膜异位的中药，所述中药的组份按重量比为杜仲10～15g、山茱萸10～15g、桃仁10～15g、益母草10～15g、红花10～15g、乌药3～5g、小茴香3～5g、败酱草15～20g、桂枝9～12g、鳖甲10～15g、田三七粉9～12g、土鳖虫9～12g、甘草3～6g。
作为一种优选方案，所述中药的组份按重量比为杜仲15g、山茱萸10g、桃仁10g、益母草15g、红花10g、乌药3g、小茴香3g、败酱草20g、桂枝9g、鳖甲10g、田三七粉9g、土鳖虫9、甘草6g。
作为另一种优选方案，所述中药的组份按重量比为杜仲15g、山茱萸15g、桃仁15g、益母草15g、红花15g、乌药5g、小茴香5g、败酱草20g、桂枝12g、鳖甲15g、田三七粉10g、土鳖虫9g、甘草3g。
上述组份中，杜仲，可补肝肾，强筋骨，主治肝肾不足，腰痛，足膝萎弱，山茱萸，含糖类和有机酸类，其性平，味酸、涩，无毒，其果实含山茱萸甙、皂甘甙、维生素A、没食子酸、苹果酸、酒石等，功能：壮元气、补肝肾、涩精气、固虚蜕，主治肾虚、耳鸣、耳聋、腰膝酸痛、阳痿遗精、小便频数、肝虚寒热、虚汗不止、月经不调、除风逐气、破症结等；桃仁含苦杏仁甙、苦杏仁酶、脂肪油等，性平，味苦、甘，功能主治，活血祛痰，润肠通便，用于经闭、痛经、症瘕痞块、跌扑损伤、肠燥便秘；益母草含益母草碱、水苏碱、芸香甙、延胡索酸，另含益母草碱甲、乙等，微寒，味苦、辛，功能主治，活血调经，利尿消肿，用于月经不调、痛经、经闭、恶露不尽，红花含红花甙，红花黄色素。另含脂肪油，称红花油，是棕榈酸、硬脂酸花生酸、亚油酸、亚麻酸、油酸等油脂类。味辛、性温，是中医常用的传统妇科良药。我国古医书中均有详实的记载和论述，能通经治血，能补能泻，能破能养，可行可导；乌药含多种倍半萜类成分香樟烯、香樟内酯、羟基香樟内酯、乌药醇、乌药醚、异乌药醚、乌药酮，性味，性温，昧辛，功能主治，顺气止痛，温肾散寒，用于胸腹胀痛、气逆喘急、膀胱虚冷、遗尿尿频、疝气、痛经；小茴香，含茴香醚、α-茴香酮、甲基胡椒酚、茴香醛等，性温，味辛，功能主治，散寒止痛，理气和胃，用于寒疝腹痛、睾丸偏坠、痛经、少腹冷痛、脘腹胀痛、食少吐泻；含白花败酱甙、莫罗忍冬甙、番木鳖甙等，功能主治：清热解毒，祛瘀排脓，用于阑尾炎、痢疾、肠炎、产后瘀血腹痛、痈肿疔疮；桂枝，本品挥发油以桂皮醛为主，尚有乙酸桂皮酯，镇痉作用，本品有抑制中枢神经作用，抗菌作用对病原性丝状菌有抑制作用，功用：温经通脉，发汗解肌，主治：风寒表证，伤风头痛，中风自汗，经闭症瘕；鳖甲性偏平和，味咸，有补肾滋阴、破瘀散结的作用，滋养同时兼祛瘀，除用于肾阴不足、潮热盗汗、手足心热外，还用于肝脾大、肝硬化、闭经等；田三七粉主治止血、散血、定痛、金刃箭伤，跌扑杖疮血出不止者，嚼料烂涂，或为末掺之，其血即止，大肠下血，妇女血崩，产后出血，产后血多，男妇赤眼，无名痈肿，虎咬虫伤等，田七主要含六种皂甙和谷甾醇、胡萝卜甙、黄酮类化合物。皂甙是人参的主要成分，对增强体力，改善心肌氧代谢，提高动物缺氧的耐受力很有作用，谷甾醇和胡萝卜甙能降血脂，而黄酮类化合物是扩张冠状动脉、改善心肌供血、增加血管弹性的有效成分；土鳖虫又称土元是一味传统的中药材，是一种名贵的凉性中药，味咸、寒，有毒，可逐瘀、破积、通络、理伤，是治疗闭经、产后瘀血腹痛、跌打损伤等症的重要药物；甘草，补脾益气，清扫解毒，祛痰止咳，缓急止痛调和诸药。用于脾胃虚弱，倦怠乏力，心悸气短，咳嗽痰多，脘腹、四肢挛急疼痛，痈肿疮毒，缓解药物毒性、烈性。甘草补脾益气复脉。用于脾胃虚弱，倦怠乏力，有调和诸药作用；中医认为，“不通则痛”，“通则不痛”，并有“腑以通为用”的观点，故以活血通腑之法，则立见其效。不过，本法用以治疗热郁血瘀、气滞血瘀者疗效最佳，一般应在经前7-10天开始服药，服至月经第5天才停服。每天1剂，水煎2次，早晚分服，连服2个月经周期为1个疗程。轻者服1个疗程即愈，重者需服2-3个疗程。眼药后痛经、性交痛、肛门坠胀痛等症状会很快消失，上述诸药配伍使用对有效治疗子宫内膜异位有独特功效，治疗时间短，效果显著，而且无任何副作用。
具体实施方式
一种实施例，治疗子宫内膜异位的中药，所述中药的组份按重量比为杜仲15g、山茱萸10g、桃仁10g、益母草15g、红花10g、乌药3g、小茴香3g、败酱草20g、桂枝9g、鳖甲10g、田三七粉9g、土鳖虫9、甘草6g。
另一种实施例，治疗子宫内膜异位的中药，所述中药的组份按重量比为杜仲15g、山茱萸15g、桃仁15g、益母草15g、红花15g、乌药5g、小茴香5g、败酱草20g、桂枝12g、鳖甲15g、田三七粉10g、土鳖虫9g、甘草3g。
Claims (3)
1、治疗子宫内膜异位的中药，其特征是：所述中药的组份按重量比为杜仲10～15g、山茱萸10～15g、桃仁10～15g、益母草10～15g、红花10～15g、乌药3～5g、小茴香3～5g、败酱草15～20g、桂枝9～12g、鳖甲10～15g、田三七粉9～12g、土鳖虫9～12g、甘草3～6g。
2、如权利要求1所述的治疗子宫内膜异位的中药，其特征是：所述中药的组份按重量比为杜仲15g、山茱萸10g、桃仁10g、益母草15g、红花10g、乌药3g、小茴香3g、败酱草20g、桂枝9g、鳖甲10g、田三七粉9g、土鳖虫9、甘草6g。
3、如权利要求1所述的治疗子宫内膜异位的中药，其特征是：所述中药的组份按重量比为杜仲15g、山茱萸15g、桃仁15g、益母草15g、红花15g、乌药5g、小茴香5g、败酱草20g、桂枝12g、鳖甲15g、田三七粉10g、土鳖虫9g、甘草3g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410024553 CN1733101A (zh) | 2004-08-13 | 2004-08-13 | 治疗子宫内膜异位的中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410024553 CN1733101A (zh) | 2004-08-13 | 2004-08-13 | 治疗子宫内膜异位的中药 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1733101A true CN1733101A (zh) | 2006-02-15 |
Family
ID=36075856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410024553 Pending CN1733101A (zh) | 2004-08-13 | 2004-08-13 | 治疗子宫内膜异位的中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1733101A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102100753A (zh) * | 2011-03-05 | 2011-06-22 | 中国农业科学院兰州畜牧与兽药研究所 | 治疗奶牛子宫内膜炎的药物 |
| CN105194180A (zh) * | 2015-11-10 | 2015-12-30 | 闫业丽 | 治疗肾虚血瘀型子宫内膜异位症的中药组合物及制法 |
| CN105362962A (zh) * | 2015-12-18 | 2016-03-02 | 钟柏根 | 一种治疗子宫内膜异位症的药物组合物及其应用 |
-
2004
- 2004-08-13 CN CN 200410024553 patent/CN1733101A/zh active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102100753A (zh) * | 2011-03-05 | 2011-06-22 | 中国农业科学院兰州畜牧与兽药研究所 | 治疗奶牛子宫内膜炎的药物 |
| CN102100753B (zh) * | 2011-03-05 | 2012-07-04 | 中国农业科学院兰州畜牧与兽药研究所 | 治疗奶牛子宫内膜炎的药物 |
| CN105194180A (zh) * | 2015-11-10 | 2015-12-30 | 闫业丽 | 治疗肾虚血瘀型子宫内膜异位症的中药组合物及制法 |
| CN105362962A (zh) * | 2015-12-18 | 2016-03-02 | 钟柏根 | 一种治疗子宫内膜异位症的药物组合物及其应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520654B (zh) | 一种用于治疗膝骨关节炎的中药组合物及其制备方法 | |
| CN101015651A (zh) | 一种治疗椎间盘突出的药物 | |
| CN102247497A (zh) | 一种治疗类风湿性关节炎的中成药 | |
| CN101269160B (zh) | 一种治疗三叉神经痛的中药组合物 | |
| CN107137499A (zh) | 一种调理身体补充元气的热敷粉包 | |
| CN103212020B (zh) | 一种治疗功能性消化不良的中药组合物 | |
| CN110585400A (zh) | 草本通康保健膏 | |
| CN112494606A (zh) | 治疗筋骨、风湿类疼痛的中药组合物及其制备方法和应用 | |
| CN105560842B (zh) | 一种治疗肝肾不足、风湿阻络型白癜风的中药制剂 | |
| CN1733101A (zh) | 治疗子宫内膜异位的中药 | |
| CN101491665B (zh) | 治疗高血压的药物 | |
| CN104758754A (zh) | 一种治疗肾气虚衰型前列腺增生的药物及制备方法 | |
| CN112263663A (zh) | 一种用于治疗阳虚体质相关妇科疾病的中药组合物 | |
| CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
| CN104127620B (zh) | 一种治疗股骨头坏死的中药制剂 | |
| CN104740144A (zh) | 一种治疗心脑血管病的中药 | |
| CN102475875A (zh) | 一种外用中药制剂及其生产方法 | |
| CN106266548A (zh) | 治疗慢性胃炎的中药组合物、制备方法及其中药制剂 | |
| CN104873858A (zh) | 一种治疗功能性痛经的中药组合物 | |
| CN105250983A (zh) | 用于治疗冻疮的药物 | |
| CN104436060A (zh) | 一种护理治疗胆管细胞癌的中药配方及其制备方法 | |
| CN105327316A (zh) | 垂体前叶机能减退症的治疗药物 | |
| CN101703664B (zh) | 一种治疗骨质增生的中药组合物 | |
| CN104840758A (zh) | 一种治疗痛经的中药组合物及制法 | |
| CN104758888A (zh) | 一种治疗消渴病的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |